Aprepitant Capsules and Dextranomer and sodium hyaluronate
Determining the interaction of Aprepitant Capsules and Dextranomer and sodium hyaluronate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: dextranomer / sodium hyaluronate
Brand name: Solesta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Dextroamphetamine
- Aprepitant Capsules-Dextroamphetamine and amphetamine
- Aprepitant Capsules-Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Aprepitant Capsules-Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
- Aprepitant Capsules-Dextroamphetamine and Amphetamine Tablets
- Aprepitant Capsules-Dextroamphetamine ER
- Dextranomer and sodium hyaluronate-Aprepitant Injection
- Dextranomer and sodium hyaluronate-Aprepitant Intravenous
- Dextranomer and sodium hyaluronate-Aprepitant Oral Suspension
- Dextranomer and sodium hyaluronate-Aprepitant/Fosaprepitant Dimeglumine
- Dextranomer and sodium hyaluronate-Apresazide
- Dextranomer and sodium hyaluronate-Apresoline